Organizations
For organizations
DisEASE gives prescribing clinicians a consistent, defensible starting point for chronic disease medication decisions, with the reasoning and the sources attached to every recommendation.
Why a panel gets more consistent
You get a consistent answer in all covered disease states, and it raises the floor of prescribing in each of them, so your clinicians do not need to be pharmacologic experts in every situation.
Quality measure performance
DisEASE is designed to improve quality measure scores, which are a key driver of reimbursement rates. The mechanism is the floor, not the ceiling: a clinician who sees chronic disease occasionally gets the same ranked options, and the same reasoning, as one who sees it all day.
Referral pressure
Giving primary care teams the confidence to manage complex pharmacotherapy is intended to postpone costly specialist referrals. Every recommendation arrives with the rules that produced it and the sources behind them, which is what makes it something a clinician can act on rather than defer.
Workload
After a plan is chosen, DisEASE drafts the assessment and plan for the clinician to review and edit before signing. The assessment builds a defensible argument for the clinician's decision, and the monitoring plan is built to follow evidence-based protocols for each intervention.
Something to point at in review
Every recommendation carries a per-rule trace: which pharmacist-verified rules fired, what each one cites, and how they combined into the ranking. The same inputs always produce the same recommendation, so a decision can be reconstructed months later rather than recalled.
What is behind it
Four chronic disease modules, each grounded in a named guideline and scored by its own deployed rule set, authored and versioned by a pharmacist.
The rules are not a black box you have to take on faith. The Clinical Proof Review publishes twelve complete workups with every ranked option, every rule that fired and every citation, so a clinical committee can evaluate the engine before anyone signs anything.
The CMS ACCESS Model
Open the ACCESS Yield CalculatorA voluntary, 10-year CMS Innovation Center model that pays primary care for outcomes in chronic care, starting with the January 2027 cohort.
The calculator estimates what a Medicare fee-for-service panel could collect under ACCESS, computed the way CMS pays: only aligned Medicare fee-for-service patients count, CMS pays 80% of the rate, and half of that is held until patients meet their measures. It is an estimate for your finance team to check, not a guarantee of payment, and it shows where DisEASE fits in bringing patients to target.
Talk to us about a pilot
Tell us the panel and the measures you are working against.